Alzheimer's Disease
New Mayo Clinic Research Reveals Molecular Clues to Alzheimer’s Disease
Health
Researchers at Mayo Clinic have identified unique molecular changes in the blood-brain barrier that could help diagnose and treat Alzheimer’s disease. Mayo ...
New Molecular Signatures Found for Alzheimer’s Disease
Health
Summary: Researchers identified unique molecular signatures of blood-brain barrier dysfunction in Alzheimer’s disease. They discovered altered communication between brain vascular cells mediated ...
Serotonin 2C Receptor Key to Memory
Health
Summary: Researchers discovered the serotonin 2C receptor in the brain plays a crucial role in regulating memory in both humans and animal ...
The Alzheimer’s drug donanemab has given me my life back
Health
I know Alzheimer’s is progressive and the condition deteriorates over time, but I’m keen to be around as long as possible for ...
Ozempic May Reduce Alzheimer’s Risk
Health
Summary: GLP-1 agonists like Ozempic reduce the risk of dementia in type 2 diabetes patients. The research followed over 88,000 individuals for ...
Synthetic Peptide Reverses Alzheimer’s Symptoms
Health
Summary: Researchers reversed Alzheimer’s symptoms in mice using a synthetic peptide, PHDP5, that targets brain function. The study shows that PHDP5 can ...
Ketones May Help Reverse Cognitive Decline
Health
Summary: As we age, our brain naturally becomes more insulin resistant, disrupting neuron communication and leading to cognitive decline and neurodegeneration. Researchers ...
‘I’ve had hallucinations of my dead cats and bump into doors’
Health
Eventually, my GP relented and I was referred to the elderly care unit. That name really upset me – to be called ...
Early Memory Complaints Linked to Alzheimer’s Brain Changes
Health
Summary: A new study finds that reports of cognitive decline from patients and their partners are linked to the accumulation of tau ...
New Alzheimer’s Breakthrough Targets Plexin-B1 Protein
Health
Summary: Researchers identified a novel way to potentially slow or halt Alzheimer’s progression by targeting the plexin-B1 protein. Their study shows how ...
